Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank check company formed to pursue a business combination in the healthcare and life sciences sector. The company completed its initial public offering in 2021 and filed a Form 10-Q with the SEC on August 15, 2022, covering its quarterly financial position as it continued its search for a target. IQMD is focused on identifying acquisition candidates in the medical technology, digital health, and broader intelligent medicine space. As of the filing date, the company remained in the target-search phase of its lifecycle. Visit SpacDesk and create a free account to access the full filing history, deal timeline, and analytics for IQMD and hundreds of other SPACs.